<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02471807</url>
  </required_header>
  <id_info>
    <org_study_id>2014-04</org_study_id>
    <nct_id>NCT02471807</nct_id>
  </id_info>
  <brief_title>Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System</brief_title>
  <official_title>Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a multi-center, prospective, early feasibility study to measure individual
      patient clinical outcomes and effectiveness, evaluate the safety and function, provide
      guidance for future clinical study designs and development efforts of the Edwards FORMA
      Tricuspid Transcatheter Repair System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The early feasibility study of the Edwards FORMA Tricuspid Transcatheter Repair System is a
      multi-center, prospective, early feasibility study to measure individual patient clinical
      outcomes and effectiveness, evaluate the safety and function, provide guidance for future
      clinical study designs and development efforts of the Edwards FORMA Tricuspid Transcatheter
      Repair System.

      Data collected in this clinical study will include safety and function of the investigational
      system as well as up to 3 year clinical outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major Adverse Event Rate</measure>
    <time_frame>30 days</time_frame>
    <description>Rates of major adverse events at 30 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device Success</measure>
    <time_frame>Intraprocedural</time_frame>
    <description>Rate of device deployment as intended</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure Success</measure>
    <time_frame>Discharge (2-8 days)</time_frame>
    <description>Rate of device success and subsequent reduction of tricuspid regurgitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Success</measure>
    <time_frame>30 days</time_frame>
    <description>Rate of procedural success without major adverse events at 30 days</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Tricuspid Valve Regurgitation</condition>
  <arm_group>
    <arm_group_label>Edwards FORMA Tricuspid Transcatheter Repair System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Edwards FORMA Tricuspid Transcatheter Repair System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Edwards FORMA Tricuspid Transcatheter Repair System</intervention_name>
    <arm_group_label>Edwards FORMA Tricuspid Transcatheter Repair System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. â‰¥ 18 years old

          2. Clinically significant, symptomatic, functional, tricuspid regurgitation (per
             applicable guidelines) requiring transcatheter tricuspid valve repair as assessed by
             the local Heart Team

        Exclusion Criteria:

          1. Tricuspid valve/right heart anatomy not suitable for the study device

          2. Moderate or greater tricuspid valve stenosis

          3. Severe RV dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lankenau Medical Center</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 11, 2015</study_first_submitted>
  <study_first_submitted_qc>June 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2015</study_first_posted>
  <last_update_submitted>July 24, 2019</last_update_submitted>
  <last_update_submitted_qc>July 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

